UBS Group Lowers Sherwin-Williams (NYSE:SHW) Price Target to $400.00

Sherwin-Williams (NYSE:SHW) had its price objective dropped by research analysts at UBS Group from $430.00 to $400.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the specialty chemicals company’s stock. UBS Group’s target price suggests a potential upside of 27.61% from the company’s current price.

SHW has been the topic of several other research reports. Jefferies Financial Group reissued a “hold” rating and issued a $380.00 target price (down previously from $423.00) on shares of Sherwin-Williams in a report on Monday, March 10th. Berenberg Bank upgraded shares of Sherwin-Williams from a “hold” rating to a “buy” rating and boosted their price target for the stock from $321.00 to $420.00 in a research note on Friday, January 24th. Royal Bank of Canada dropped their price objective on shares of Sherwin-Williams from $438.00 to $415.00 and set an “outperform” rating for the company in a report on Monday, February 3rd. Barclays decreased their target price on Sherwin-Williams from $385.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 1st. Finally, Wells Fargo & Company cut their price target on Sherwin-Williams from $400.00 to $380.00 and set an “equal weight” rating for the company in a report on Thursday, April 3rd. Six research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $395.19.

Sherwin-Williams Stock Down 2.9 %

Shares of SHW stock opened at $313.44 on Monday. The company has a market capitalization of $78.83 billion, a price-to-earnings ratio of 29.71, a PEG ratio of 2.98 and a beta of 1.26. The company has a debt-to-equity ratio of 2.02, a current ratio of 0.79 and a quick ratio of 0.46. The company’s fifty day moving average price is $349.46 and its 200-day moving average price is $361.52. Sherwin-Williams has a one year low of $282.09 and a one year high of $400.42.

Sherwin-Williams (NYSE:SHW) last announced its quarterly earnings data on Thursday, January 30th. The specialty chemicals company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.07 by $0.02. Sherwin-Williams had a return on equity of 74.50% and a net margin of 11.61%. During the same period in the prior year, the business earned $1.81 EPS. Sell-side analysts expect that Sherwin-Williams will post 12 EPS for the current fiscal year.

Insider Buying and Selling at Sherwin-Williams

In related news, insider Colin M. Davie sold 2,799 shares of the firm’s stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $360.30, for a total transaction of $1,008,479.70. Following the completion of the sale, the insider now directly owns 5,365 shares of the company’s stock, valued at approximately $1,933,009.50. This trade represents a 34.28 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Sherwin-Williams

Several hedge funds have recently bought and sold shares of the business. Legacy Capital Wealth Partners LLC grew its holdings in shares of Sherwin-Williams by 2.9% in the fourth quarter. Legacy Capital Wealth Partners LLC now owns 1,028 shares of the specialty chemicals company’s stock worth $350,000 after purchasing an additional 29 shares during the last quarter. Apella Capital LLC grew its stake in Sherwin-Williams by 2.1% in the 4th quarter. Apella Capital LLC now owns 1,465 shares of the specialty chemicals company’s stock worth $498,000 after acquiring an additional 30 shares in the last quarter. Atlantic Edge Private Wealth Management LLC increased its position in shares of Sherwin-Williams by 0.8% during the fourth quarter. Atlantic Edge Private Wealth Management LLC now owns 3,742 shares of the specialty chemicals company’s stock worth $1,272,000 after acquiring an additional 30 shares during the period. IMS Capital Management raised its stake in shares of Sherwin-Williams by 2.4% during the fourth quarter. IMS Capital Management now owns 1,287 shares of the specialty chemicals company’s stock valued at $437,000 after acquiring an additional 30 shares in the last quarter. Finally, Coppell Advisory Solutions LLC raised its stake in shares of Sherwin-Williams by 2.7% during the fourth quarter. Coppell Advisory Solutions LLC now owns 1,146 shares of the specialty chemicals company’s stock valued at $388,000 after acquiring an additional 30 shares in the last quarter. Institutional investors own 77.67% of the company’s stock.

Sherwin-Williams Company Profile

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.